SAN
DIEGO, Feb. 25, 2025 /PRNewswire/ -- Neurocrine
Biosciences, Inc. (Nasdaq: NBIX) will participate at two upcoming
investor conferences in March.
- Chief Executive Officer Kyle
Gano, Chief Financial Officer Matt
Abernethy, and Chief Commercial Officer Eric Benevich will present at the TD Cowen
45th Annual Health Care Conference on Tuesday, March 4, 2025 at 11:10 AM Eastern Time in Boston.
- Chief Financial Officer Matt
Abernethy and Vice-President of Investor Relations
Todd Tushla will present at the
Leerink Global Healthcare Conference on Tuesday, March 11, 2025 at 11:20 AM Eastern Time in Miami.
The live webcasts can be accessed on Neurocrine Biosciences'
website under Investors at www.neurocrine.com. A replay of the
webcasts will be available on the website approximately one hour
after the conclusion of the events and will be archived for
approximately one month.
About Neurocrine Biosciences
Neurocrine Biosciences is
a leading neuroscience-focused, biopharmaceutical company with a
simple purpose: to relieve suffering for people with great needs.
We are dedicated to discovering and developing life-changing
treatments for patients with under-addressed neurological,
neuroendocrine and neuropsychiatric disorders. The company's
diverse portfolio includes U.S. FDA-approved treatments for tardive
dyskinesia, chorea associated with Huntington's disease, classic congenital
adrenal hyperplasia, endometriosis* and uterine fibroids*, as well
as a robust pipeline including multiple compounds in mid- to
late-phase clinical development across our core therapeutic areas.
For three decades, we have applied our unique insight into
neuroscience and the interconnections between brain and body
systems to treat complex conditions. We relentlessly pursue
medicines to ease the burden of debilitating diseases and
disorders, because you deserve brave science. For more information,
visit neurocrine.com, and follow the company on LinkedIn, X
(Formerly Twitter) and Facebook.
(*in collaboration with AbbVie)
The NEUROCRINE BIOSCIENCES Logo Lockup and YOU DESERVE BRAVE
SCIENCE are registered trademarks of Neurocrine Biosciences,
Inc.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/neurocrine-biosciences-to-present-at-upcoming-investor-conferences-in-march-302385110.html
SOURCE Neurocrine Biosciences, Inc.
